Search
Sotalol
go.drugbank.com/drugs/DB00489ApprovedInvestigationalSotalol is a methanesulfonanilide developed in 1960.[A178579] It was the first of the class III anti arrhythmic drugs.[A178579] Sotalol was first approved as an oral tablet on 30 October 1992. … [L6334] A racemic mixture of sotalol is currently formulated as a tablet, oral solution, and intravenous injection indicated for life threatening ventricular arrhythmias and maintaining normal sinus rhythm
Categories: Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Medications that reduce magnesium levelsInternational brands: Xi An Lin, Tan ShiOmeprazole
go.drugbank.com/drugs/DB00338ApprovedInvestigationalVet approvedOriginally approved by the FDA in 1989, omeprazole is a _proton-pump inhibitor_, used to treat gastric acid-related disorders. … These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid.
Mixtures: DOLOTECH TABLETA RECUBIERTA DE LIBERACION RETARDADA, SEVEFIEST TABLETA RECUBIERTA DE LIBERACION RETARDADACategories: Medications that reduce magnesium levelsChlorpheniramine
go.drugbank.com/drugs/DB01114ApprovedInvestigationalOne of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than promethazine. … A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications.
Mixtures: K.B. FEDAMOL, Chlor-Tan A 12 SuspensionCategories: Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeCefixime
go.drugbank.com/drugs/DB00671ApprovedInvestigational[A232920, A232925, A232930] Cefixime is a broad-spectrum antibiotic and an orally-active third-generation semisynthetic cephalosporin. … [A262894,A263011 ,L49293] Cephalosporins are beta-lactam antibiotics and can be used to treat gram-positive and gram-negative bacterial infections which include conditions such as skin infections, resistant
Mixtures: INNOCEF PLUS 200/125 MG SAŞE, 20 ADET, INNOCEF PLUS 400/125 MG SAŞE, 10 ADETProducts: CEFIXIMA HEXAL AG, CEFIXIM AL 200MGAtenolol
go.drugbank.com/drugs/DB00335ApprovedInvestigationalAtenolol is a cardioselective beta-blocker used in a variety of cardiovascular conditions. … [A235850,A235855] A Cochrane review of patients being treated for primary hypertension shows that atenolol shows a risk ratio of 0.88 for cardiovascular disease risk and a risk ratio of 0.99 for mortality
Mixtures: Aa-atenidone, Aa-atenidoneProducts: AS-ATENS 100 MG TABLET, TABLET, 28 ADET, Ag-atenololHydroxocobalamin
go.drugbank.com/drugs/DB00200ApprovedInvestigationalHydroxocobalamin, also known as vitamin B12a and hydroxycobalamin, is an injectable form of vitamin B 12 that has been used therapeutically to treat vitamin B 12 deficiency. … It is also used in cyanide poisoning, Leber's optic atrophy, and toxic amblyopia.
Mixtures: TRIBENA APProducts: VITAMIN B12 DEP PAN 1000UG, VITAMIN B12 DEP INJ 1500UGMebendazole
go.drugbank.com/drugs/DB00643ApprovedInvestigationalVet approvedA benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of microtubules. [PubChem]
Mixtures: L-OMBRIX-DUET, L-OMBRIX-DUETProducts: K.B. BENDAZOLE SYRUP, PIPERAWITT NFVerapamil
go.drugbank.com/drugs/DB00661ApprovedInvestigationalgreater potency than the R-enantiomer, but is metabolized at a higher rate. … [L8791] Verapamil is administered as a racemic mixture containing equal amounts of the S- and R-enantiomer, each of which is pharmacologically distinct - the S-enantiomer carries approximately 20-fold
Mixtures: TARKA 180/2 FILM TABLET, 28 ADET, VERACOMB MR 180/2 MG KAPSÜL, 28 ADETProducts: VERAPAMIL AL 240 RET, Aa-verapFlutamide
go.drugbank.com/drugs/DB00499ApprovedInvestigationalAn antiandrogen with about the same potency as cyproterone in rodent and canine species.
Products: ETACONIL DE 250 MG COMPRIMIDOS, FLUTAMID AL 250Colfosceril palmitate
go.drugbank.com/drugs/DB09114ApprovedWithdrawnColfosceril palmitate is a synthetic pulmonary surfactant administered in infants with respiratory distress syndrome. … [A31510] It was part of the first generation of commercially available artificial surfactants.[T70] It was developed by Burroughs Wellcome and it was FDA approved on August 6, 1990.
Synonyms: Palmitate de colfosceril, Palmitato de colfoscerilo